Why Choose Almond Pharma?
Benefit From Years Of Experience
According to Module VI of the EU Guideline of Good Pharmacovigilance Practices (GVP) , the regulators expect every marketing authorisation holder to incorporate literature screening procedures as an integral part of your daily drug safety operations.
Almond Pharma operate a comprehensive Worldwide Pharmacovigilance Literature Screening Service as part of our drug safety services. With the use of databases like Embase and Medline.
At least once a week, we will systemically monitor the “active substances”, assessing the relevant database by screening abstracts for the identification of:
The benefit of contracting Almond Pharma to do your Literature Screening for you is that our team have years of experience in this particular area and can comprehensively manage your literature screening requirements in the most cost-effective way possible.
For purposes of signal evaluation, we can also carry out identifying safety concerns for inclusion in PSURs or literature searches.
© 2020 ASAAL ltd
Registered in the UK, Company number 06830591